Nasdaq IPOs

Fortress Value Acquisition II, the second blank check company formed by executives at Fortress Investment Group, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 milli

Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex (VERX). A handful of companies could join the IPO calendar in the coming week, including leading mortgage lender Rocket Companies (RKT), cloud hosting service provider Racks

Car House Holding, which operates an online B2B marketplace for car products in China, announced terms for its IPO on Friday. The Guangdong, China-based company plans to raise $27 million by offering 3.9 million shares at a price range of $6.50 to $7.50. At the midpoint of the pr

Li Auto, which manufactures smart electric SUVs in China, announced terms for its IPO on Friday. The Beijing, China-based company plans to raise $855 million by offering 95 million ADSs at a price range of $8 to $10. New investor Hillhouse Capital intends to purchase $300 million

Dragoneer Growth Opportunities, a blank check company formed by Dragoneer Investment Group, filed on Friday with the SEC to raise up to $600 million in an initial public offering. The San Francisco, CA-based company plans to raise $600 million by offering 60 million units at a pr

CureVac, a German Phase 1 biotech developing mRNA-based cancer therapies and vaccines, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company's pipeline contains lead candidates CV8102, which is currently in a Phase 1 trial for so

KE Holdings, China's largest housing transactions and services platform, filed on Friday with the SEC to raise up to $1.0 billion in an initial public offering. The company's Beike platform is China's largest housing transactions and services platform and its second largest comme

Vital Farms, the largest US producer of pasture-raised eggs and butter, announced terms for its IPO on Friday. The Austin, TX-based company plans to raise $125 million by offering 7.8 million shares (35% insider) at a price range of $15 to $17. At the midpoint of the proposed ran

Inozyme Pharma, a preclinical biotech developing protein therapies for rare calcification diseases, raised $112 million by offering 7 million shares at $16, in line with the upwardly revised terms. The company offered 0.5 million more shares than anticipated. It originally f

Annexon, a Phase 1 biotech developing therapies for rare autoimmune diseases, raised $251 million by offering 14.8 million shares at $17, above the narrowed range of $15 to $16. The company offered 2.3 million more shares than anticipated. It originally planned to offer 10 m

iTeos Therapeutics, a Phase 1/2 immuno-oncology biotech developing therapies for various cancers, raised $201 million by offering 10.6 million shares at $19, above the range of $16 to $18. The company originally planned to offer 8.9 million shares. At pricing, iTeos commands a fu

Nurix Therapeutics, a preclinical biotech developing small molecule therapies for cancer, raised $209 million by offering 11 million shares at $19, above the narrowed range of $17 to $18. The company originally planned to offer 8.8 million shares at a range of $16 to $1

Greencity Acquisition, a blank check company focused on businesses in Asia, raised $40 million by offering 4 million units at $10. Each unit consists of one share of common stock and one warrant, exercisable at $11.50. At pricing, Greencity Acquisition commands a market value of

PaxMedica, a Phase 2 biotech developing therapies for neurodevelopmental disorders, announced terms for its IPO on Thursday. The Woodcliff Lake, NJ-based company plans to raise $15 million by offering 2.5 million shares at a price range of $5.50 to $6.50. At the midpoint of the p

Duck Creek Technologies, which provides a SaaS platform that streamlines business processes for P&C insurers, filed on Thursday with the SEC to raise up to $200 million in an initial public offering. The company's Duck Creek Suite enables carriers to develop and manage policy

Ascendant Digital Acquisition, a blank check company targeting an interactive digital entertainment business, raised $360 million by offering 36 million units at $10. The company originally planned to offer 30 million units. Each unit consists of one share of common stock and one

Inhibikase Therapeutics, a clinical stage biotech developing therapies for Parkinson's and related disorders, filed on Thursday with the SEC to raise up to $18 million in an initial public offering. The company's pipeline contains lead candidate IkT-148009, a c-Abl protein k

Billionaire Elon Musk's SpaceX is looking to raise new capital at a valuation of about $44 billion, Bloomberg News reported on Thursday, citing people familiar with the matter.

Pershing Square Tontine Holdings (PSTHU) raised $4 billion and traded up 6.5% yesterday, becoming the largest Special Purpose Acquisition Company (SPAC) ever to go public. It is the latest milestone in a record-breaking year for SPACs. To screen for upcoming or past SPAC IPOs, si

Pershing Square Tontine Holdings (PSTHU) raised $4 billion and traded up 6.5% yesterday, becoming the largest Special Purpose Acquisition Company (SPAC) ever to go public. It is the latest milestone in a record-breaking year for SPACs. To screen for upcoming or past SPAC IPOs, si